IDS Bone Turnover Markers (BTM) for use with cell culture and animal models.
When addressing changes in bone turnover at the organ or organism level, monitoring tools adequately reflecting the outcome of tissue homeostasis become particularly critical. In this context, bioassays targeting the quantification of various degradation and formation products of bone matrix elements represent a useful approach1.
Every day more and more newborns are screened worldwide for metabolic and endocrine disorders. Although screening for haemoglobin has a long history in some countries (USA or UK), in other countries it is a recent addition to their screening panels (Portugal; Germany).
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Linearity and calibration verification– confirmation of test stability throughout reportable ranges with VALIDATE® from Maine Standards.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
C-reactive protein (CRP) is a widely used analyte in healthcare, but do you know why it’s beneficial to measure CRP using point-of-care (POC) testing?
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Haemoglobinopathies, such as sickle cell disease and alpha/beta thalassemia major, are prevalent genetic disorders that affect the protein part of haemoglobin (Hb).
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
VALIDATE® Hemostatsis – Linearity and Calibration Verification Test Kits for Clinical Analysers
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Sebia FLC Kappa and Sebia FLC Lambda – Measurement of FLC can be complex and challenging for many laboratories using traditional turbidimetric or nephelometric methods.
Products are for professional/laboratory use only.
IDS cartilage markers, supporting early identification of cartilage damage by providing dynamic assessment of cartilage destruction.
Products are for professional/laboratory use only.
Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge.
Urinary C-terminal crosslinked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers.